Intermediates

2,5-Dimercapto-1,3,4-thiadiazole

  • CAS No.1072-71-5
  • GradeIndustrial / Pharmaceutical
  • Availability● In Stock

High-purity 2,5-Dimercapto-1,3,4-thiadiazole (CAS 1072-71-5), a key pharmaceutical intermediate for cephalosporin antibiotic synthesis such as cefazolin and cefcanel.

Request Bulk Pricing

Product Technical Details

Product Overview

2,5-Dimercapto-1,3,4-thiadiazole (CAS 1072-71-5), commonly referenced under the historical name Bismuththiol, is a high-value heterocyclic organic compound widely employed as a critical building block in the pharmaceutical industry. This sulfur-rich molecule serves as an essential intermediate in the synthesis of first-generation cephalosporin antibiotics, including cefazolin and cefcanel. With its dual thiol functionality and stable thiadiazole core, it enables precise molecular construction during complex beta-lactam antibiotic manufacturing.

Specifications

Molecular FormulaC₂H₂N₂S₃
Molecular Weight150.25 g/mol
Melting Point≥160.0 °C (typical range: 160.3–162.3 °C)
Density1.8 g/cm³
Boiling Point211.3 °C
Refractive Index1.807
AppearanceOff-white to yellow crystalline powder
Assay (Purity)≥98.0% (typical result: 98.06%)
Loss on Drying≤0.5% (typical result: 0.23%)
Residue on Ignition≤0.5% (typical result: 0.26%)

Industrial Applications

As a specialized pharmaceutical intermediate, 2,5-Dimercapto-1,3,4-thiadiazole is primarily utilized in the multi-step synthesis of cephalosporin-class antibiotics. Its role is pivotal in constructing the side-chain architecture required for biological activity. Key advantages include:

  • High reactivity of dual thiol groups enabling selective derivatization
  • Excellent batch-to-batch consistency meeting stringent GMP requirements
  • Compatibility with large-scale API manufacturing processes
  • Stable under standard storage conditions, ensuring long shelf life

Stored in a cool, well-ventilated area away from oxidizing agents, this compound is typically supplied in 25 kg fiber drums or customized packaging per client specifications. All batches are accompanied by a comprehensive Certificate of Analysis (COA) and full regulatory documentation for seamless integration into global pharmaceutical supply chains.